LIVE
World · Global leaders push a fresh climate funding deal before COP talksAsia · Asia chip supply routes shift after new export rulesEurope · European energy grids brace for another summer peakAmericas · Americas central banks signal patience on rate cutsAfrica · East Africa digital payments surge as cross-border rails expandMiddle East · Gulf ports invest in green shipping hubsIndia · India monsoon outlook puts food inflation back on watchTech · AI regulation frameworks diverge across major blocsBusiness · Container rates ease on key Asia–Europe lanesScience · Mars sample return prep moves into a tighter engineering phaseClimate · Cities trial cool-roof mandates to cut urban heatSports · World athletics records tumble across Diamond League meetsWorld · Global cyber alert hits hospital networks in three regionsAsia · Asia tourism rebounds as visa rules ease across hubsWorld · Global leaders push a fresh climate funding deal before COP talksAsia · Asia chip supply routes shift after new export rulesEurope · European energy grids brace for another summer peakAmericas · Americas central banks signal patience on rate cutsAfrica · East Africa digital payments surge as cross-border rails expandMiddle East · Gulf ports invest in green shipping hubsIndia · India monsoon outlook puts food inflation back on watchTech · AI regulation frameworks diverge across major blocsBusiness · Container rates ease on key Asia–Europe lanesScience · Mars sample return prep moves into a tighter engineering phaseClimate · Cities trial cool-roof mandates to cut urban heatSports · World athletics records tumble across Diamond League meetsWorld · Global cyber alert hits hospital networks in three regionsAsia · Asia tourism rebounds as visa rules ease across hubs
desk just now
TheEbenezer News

Business

Ozempic Maker Novo Nordisk’s Investors AreNervously Looking Into the Future

Novo Nordisk’s chief executive, Mike Doustdar, is a year into a corporate turnaround. He says investors are still underestimating the promise of the company’s drugs.

This story summarizes reporting from The New York Times. Read the original for full context. Wire items stay in our news sitemap for seven days. Editorial policy.

Read full story on The New York Times
Eshe Nelson1 Sept 2026, 05:09 pmUpdated 1d ago1 min readBusinessGlobal
Ozempic Maker Novo Nordisk’s Investors Are Nervously Looking Into the Future

GlobalEshe Nelson

Novo Nordisk’s chief executive, Mike Doustdar, is a year into a corporate turnaround. He says investors are still underestimating the promise of the company’s drugs.

This report is published with credit to The New York Times. The wire sent a summary; open the original for any extra context. Read on The New York Times

Source: The New York Times · Eshe Nelson. Published 1 Sept 2026, 05:09 pm.

Keep reading

Back to the desk
info@ebenezerdigital.com+91 98944 96560WhatsApp

Privacy · Terms · Sitemap